Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $81 From $80, Maintains Buy Rating
Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance
TD Cowen Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $70
Piper Sandler Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $70
Oppenheimer Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $90
Edwards Life Says Pivotal Study for Evoque Hit One-year Goal